Vanderbilt University Medical Center
Nashville, Tennessee, 37203, United States
NCT Number: NCT06180850
Lipedema is a disease marked by subcutaneous adipose tissue accumulation in the lower extremities of females that is accompanied by somatic pain and edema. Importantly, lipedema is commonly misdiagnosed as obesity, although it's estimated to affect a high 11% of women. Clinical diagnosis of lipedema requires specialized training not widely available at most major medical centers, and there remains a substantial need for objective tools to distinguish lipedema from obesity. There is a critical need to define specific molecular markers of disease in circulation or at the tissue-level. The purpose of this study is to create, manage, and characterize an innovative lipedema biorepository. The goal of the biorepository will be to better understand disease mechanisms of lipedema and to define specific molecular markers of disease in circulation or at the tissue-level. The long-term purpose of our studies are to help with prevention and early management of lipedema.
Looking for future studies?
Notify Me18 year–80 year
Female
Observational
Nashville, Tennessee, 37203, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Volunteers in the lipedema or control group will be excluded with the following:
Also excluded are subjects incapable of giving informed written consent:
Time frame: 1 day
Time frame: 1 day
Time frame: 1 day
Time frame: 1 day
Time frame: 1 day
Looking for future studies?
Notify MeVanderbilt University Medical Center
Other
Acronym: BRR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05966779
Assessment, Cardiovascular Diseases
Alcalá de Henares, Madrid, Spain
View Trial DetailsNCT07808242
Connective Tissue Diseases, Hypermobility, Joint
Izmir, Turkey (Türkiye)
View Trial DetailsNCT05739279
Atrophy, Connective Tissue Diseases
Izmir, Turkey (Türkiye)
View Trial DetailsNCT07787234
Body Weight, Connective Tissue Diseases
Istanbul, Uskudar, Turkey (Türkiye)
View Trial Details